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ABSTRACT 
The onslaught of COVID-19 pandemic has greatly overwhelmed some of the best healthcare 
systems in the world. Medical practitioners working in hospitals at the epicenters of COVID-
19 pandemic have emphasized on the need to manage mildly ill and convalescent COVID-19 
patients at home or community facilities rather than at hospitals during a pandemic. In this 
article, we highlight that a standardized home- and community-based (HCBC) approach for 
management of COVID-19 patients will be a key component for preparing hospitals in sub-
Saharan Africa (SSA) for a potential surge in COVID-19 cases. So far, based on the 
trajectory of infection, we think that SSA seems to have a window of opportunity, albeit 
narrowing, for implementing HCBC. However there are challenges that will need to be 
addressed in order to implement and maintain HCBC. Successful implementation and 
maintenance of HCBC in SSA will require international agencies and key donors to work 
closely with the national governments; providing them with policy, technical, and financial 
assistance. HCBC is also important because it can play a role in advocacy, education, 
training, and health promotion during COVID-19 pandemic. We further underscore the need 
for a delicate balance between HCBC and hospital-based care (HBC) approach as well as 
with COVID-19 mitigation and suppression measures in order to reduce the risk of SARS-
CoV-2 community transmission and allow optimal continuity of the HBC. We conclude by 
emphasizing once again that, for countries in SSA to adequately prepare for the worst-case 
scenario of COVID-19 pandemic in the absence of a cure, policy makers of member states 
need to act collectively and fast. 
Keywords: SARS-CoV-2, COVID-19, Pandemic, Healthcare, Hospital-based care (HBC), 
Home- and community-based care (HCBC), Sub-Saharan Africa (SSA) 
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INTRODUCTION 
As COVID-19 pandemic sweeps across the globe, it continues to precipitate 
inconceivable sociocultural, health, and economic mayhems. By mid-April 2020, over 2.0 
million people were infected with SARS-2-CoV-2 globally; with the US and Western Europe 
rapidly overtaking China by approximately eight- to twelve-fold to become the new 
epicenters of the pandemic. This upward infection trajectory, especially in countries such as 
Italy and Spain might not be surprising as it is believed that at the onset of the SARS-CoV-2 
outbreak, countries’ mitigation efforts to control the epidemic were “too little” and “too 
late”.
1
 As of 8 June 2020 (00:00 GMT), over 7.0 million people were infected with SARS-
CoV-2 globally; with the number of confirmed cases in several countries, including Russia, 
India, Brazil and the United Kingdom to mention a few, greatly surpassing the number of 
cases in China.
2
 Although the importation risk of COVID-19 to Africa was estimated to be
eleven times lower than that to Europe,
3
 the pandemic has already found a foothold in Africa.
Notwithstanding, this global outbreak displays an uneven geographical distribution in Africa. 
So far, the continent has 191,862 confirmed cases and 5,203 deaths.
2
 Each of these represents
a small yet increasing proportion of the global confirmed cases and deaths (2.7% and 1.3%, 
respectively). There has been growing concerns about the impact of COVID-19 pandemic on 
the African continent. For example, based on modelling and population-based intervention 
analyses, Walker and colleagues estimated that Africa could have 1.0 billion SARS-CoV-2 
infections and 2.5 million deaths this year, following an unmitigated pandemic.
4
 However,
the three-month infection trajectory of COVID-19 cases in African countries seems to be 
quiet unique compared to the epidemic in other parts of the world. The infections are not 
growing faster as predicted. These slow infection trajectories in Africa could be due to i) 
timely implementation of containment measures (in order to reduce COVID-19 importation 
risk), ii) low SARS-CoV-2/COVID-19 testing capacity (thus, underestimating the cases), iii) 
warm weather (which could be reducing or precluding the spread of infection), iv) Africa’s 
young population (which could offer protection against the infection), and v) pre-existing 
BCG vaccination programmes (which is thought could reduce the impact of the pandemic). In 
spite of the unique infection trajectories, African countries should still be concerned over the 
rising COVID-19 cases. This is because the healthcare systems in these countries are weak 
despite the need for healthcare prioritization by their governments. Concurrent with this, 
there is currently no specific therapy for COVID-19 despite the ongoing global advances in 
the development of COVID-19 drugs and vaccines. 
The onslaught of the pandemic has greatly strained some of the best healthcare systems 
in the world. For instance, in Daegu and Gyeongbuk (South Korea), the rapid surge in 
COVID-19 cases resulted in shortage of hospital beds. Consequently, this forced some of the 
COVID-19 patients to stay and/or die at their homes while awaiting admissions.
5
 In
Lombardy (Italy), one of the initial responses to the outbreak was to increase the intensive 
care unit (ICU) surge capacity.
6
 However, the hospital-based care (HBC), including ICU
care, rapidly reached its saturation and was at the verge of collapsing.
7
 The surge in COVID-
19 cases resulted in overcrowding in hospitals, fatigued healthcare workers (HCWs), in-
hospital SARS-CoV-2 transmission, prioritization of ICU care according to patients’ chances 
of surviving, struggle to deliver regular healthcare services, suspension of vaccination 
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programmes, and lack or inadequate vital medical supplies and equipment.
7
 An
unmanageable COVID-19 pandemic, compounded by inadequate personal protective 
equipment (PPE), may potentially expose HCWs to COVID-19. The strain posed on HBC 
systems by the raid surge in COVID-19 patients therefore begged the question of whether 
out-of-hospital care approaches, specifically home- and community-based care (HCBC), 
could be exploited to provide adequate healthcare to COVID-19 patients without overloading 
the HBC system. To achieve this, several medical practitioners working at COVID-19 
epicenters in Italy emphasized that, “In a pandemic, patient-centered care is inadequate and 
must be replaced by community-centered care”.
7
 Parallel with this appeal, the World Health
organization (WHO) published its interim guidance for provision of safe home care for 
COVID-19 patients “when inpatient care is unavailable and unsafe”.
8
 Fairly recently, South
Korea implemented a resource-saving and cost-effective out-of-hospital cohort care termed as 
community treatment center (CTC). CTCs are designed for treating mild cases of COVID-19 
while allowing for cohort isolation (so as to prevent transmission) and restricting 
hospitalization to patients with severe symptoms.
5
With the continued spread of SARS-CoV-2 infection in sub-Saharan Africa (SSA) and 
signs for possible relaxation of lockdowns and curfews lifting in order to save the economy, 
particularly in the absence of specific antiviral treatment for COVID-19 and limited HBC 
capacity, there is an urgent need for careful consideration of HCBC for management of 
COVID-19 patients. 
DISCUSSION 
Feasibility and Relevance of Home- and Community-Based Care and Patient 
Management in Sub-Saharan Africa: Requirements and Challenges 
But how feasible and pertinent is HCBC in SSA, especially amid minimal supplies of 
medical resources (including PPE) and inadequate COVID-19 isolation facilities? As already 
known, there is lack of hospital capacity in SSA
4,9
 concomitant with increased burden of
nosocomial infections as well as communicable and non-communicable diseases,
9
 e.g.,
malaria, HIV/AIDS, tuberculosis, diabetes, chronic respiratory conditions, and cancer. Some 
of these diseases are associated with poor clinical outcomes of COVID-19.
10
 Nosocomial
infections have been reported among hospitalized COVID-19 patients,
10
 and may cause
financial burden (due to extended hospitalizations) and death of patients. Given the 
unprecedented healthcare challenges staring at the fragile healthcare systems in SSA, it 
therefore seems logical to assume that HBC in SSA will be inadequate for a surged COVID-
19 pandemic. Even if surged COVID-19 cases do not occur in countries in SSA, the few 
available hospitals could be overwhelmed by the COVID-19 cases. Thus, it would be 
advisable for the major stakeholders, including policy makers, in the healthcare system in the 
respective countries in SSA to tackle COVID-19 pandemic from a HCBC approach. This 
could be intertwined with community screening and testing. HCBC will be a key component 
of preparing healthcare facilities for a potential surge in COVID-19 cases, in addition to 
eliminating or minimizing further burden on the already stretched HBC systems. 
The success of HCBC will greatly depend on the availability of basic shelter, mobile 
clinics/field hospitals, community facilities (e.g., repurposed hotels, gymnasiums, and 
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stadiums), essential medical resources (medicines, beds, and equipment), reliable road 
infrastructure, good infection prevention and control (IPC) measures, proper healthcare risk 
waste mismanagement as well as good national policy, political will, and governance. 
Additionally, HCBC will need a new cadre of community staff with the spirit of humanity 
and COVID-19 patients attended to irrespective of their income and medical covers. Despite 
the need for rapid widespread campaign and implementation of HCBC in countries in SSA 
during COVID-19 pandemic, there are certain healthcare issues and challenges
9,11,12
 that
could potentially impede its adoption. Adoption of HCBC may be limited by: 
i. Working poverty and lack of basic sanitation facilities and supporting
infrastructures.
ii. Little, delayed, and slow efforts by the stakeholders in healthcare in adopting
HCBC.
iii. Shortages and unequal distribution of trained staff.
iv. Frequent periodic supply shortages and stock-outs of vital medicines and limited
medical equipment.
v. High burden of disease epidemics.
vi. Unwillingness of COVID-19 patients and their contacts to be enrolled in HCBC
due to stigma against COVID-19.
vii. Looming and cascading concerns about the possibility of adverse health
outcomes during the COVID-19 management period.
viii. Safety of home- and community-based carers, which may limit the amount of
work performed by community HCWs.
ix. Conflict between modern medicine and alternative medicine, including traditional
medicine.
x. Difficulty in establishing a balancing HCBC care and HBC as well as COVID-19
countermeasures.
xi. Environmental hazards due to poor hygiene and IPC measures, and healthcare
risk mismanagement.
xii. Poor-record keeping which might compromise patient care and its continuum.
xiii. Different COVID-19 patient needs and increased patient needs and expectation.
xiv. Lack of education and training for COVID-19 patients and community HCWs.
xv. Possibility of medical litigation due to patient negligence.
xvi. Ailing economy and limited funding parallel with management and leadership
crisis.
Therefore, the success of HCBC will greatly depend on the availability of basic shelter, 
mobile clinics/field hospitals, community facilities (e.g., repurposed hotels, gymnasiums, and 
stadiums), essential medical resources (medicines, beds, and equipment), reliable road 
infrastructure, good IPC measures, safe healthcare risk waste mismanagement as well as good 
national policy, political will, and governance. Additionally, HCBC will need a new cadre of 
empowered community staff with the spirit of humanity and COVID-19 patients attended to 
irrespective of their income and medical covers. Instituted national programmes will be 
needed to monitor and evaluate the impact of HCBC. There are lessons that could be adopted 
from pre-existing home-based care policies for fighting disease epidemics such as HIV. To 
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implement and sustain an effective HCBC for COVID-19 pandemic in SSA, international 
agencies (e.g., African Union Commission, Africa Centers for Disease Control and 
Prevention (Africa CDC) and WHO) and key donors might need to work closely with the 
national governments; providing them with policy and technical guidance, and financial 
support. 
Under the HCBC approach, standardized procedures could be used to triage COVID-19 
patients to apposite healthcare needs based on the patterns of disease progression. This could 
be bolstered by use of point-of-care testing, such as lactate dehydrogenase/glucose ratio, C-
reactive protein, and lymphocyte count, as well as pulse oximetry in order to determine 
patients who need hospitalization. Severity of lymphocytopenia for example, has been 
posited to show severity of COVID-19.
10
 Persons with suspected COVID-19 and those with
mild symptoms and no risk factors (underlying chronic conditions) who do not need 
hospitalization can be managed under HCBC in accordance with international health 
guidelines,
8
 until their symptoms resolve and SARS-CoV-2 tests are negative.
What Role Can Home- and Community-Based Care Play in the Fight Against SARS-
CoV-2/COVID-19? 
HCBC can play a role in advocacy, education, training, and health promotion. Such 
include regularly mobilizing the community and taking part in campaigns geared towards 
educating the community about the potential risk of COVID-19 and empowering them on the 
importance of mitigation and suppression measures – hand hygiene practices, respiratory 
etiquette, social distancing, lockdowns, etc. COVID-19 information material and resources 
(including digital advocacy) should be readily available in local languages in order to capture 
a targeted and wider audience. These, together with patient education on COVID-19, will 
further mitigate SARS-CoV-2 transmission. Education and training should be supplemented 
by good counselling that prevents panic, stigmatization, social discrimination, and patient-
attack associated with COVID-19. 
Need for a Balanced Hospital-Based Care and Home- and Community-Based Care 
Approach 
With the advent of HCBC and consideration to adopt it by countries such as South Africa 
and Kenya, there is need to establish a balance between HCBC and HBC approach for 
COVID-19 in SSA. HCBC requires a well-coordinated and robust communication link with 
HBC. Furthermore, a balance of HCBC approach with community isolation and IPC 
measures for COVID-19 ought to be considered. This is primarily intended to reduce the risk 
of SARS-CoV-2 onward transmission and “flatten the curve”, hence allowing optimal 
continuity of the HBC. In tandem with COVID-19 containment and mitigation policies, 
HCBC could also encompass drone technology and telemedicine, in order to deliver 
healthcare services to COVID-19 patients (recent cases, convalescents, and survivors), while 
preventing HCWs from potential COVID-19 and nosocomial infections. Patients under 
HCBC could be clinically managed with available therapies that do not necessarily require 
hospitalization and new therapies as good clinical data becomes available. More importantly, 
comorbidities should be taken into considerations during HCBC. Regular follow-ups will be 
required to ensure that COVID-19 patients fully recover or are timely transferred to hospitals 
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if necessary. HCBC will need community HCWs and specific household members to be 
trained on how to manage COVID-19 patients and themselves at home and community 
facilities according to the current WHO recommendations.
8
CONCLUSIONS 
Because the pandemic has not yet stamped its authority in Africa, SSA seems to have a 
critical window for implementing HCBC, though this is closing with time as the number of 
COVID-19 cases continues to rise. Nonetheless, it should once again be emphasized that in 
order for Africa to prepare for the worst-case scenario of COVID-19 pandemic in the absence 
of a cure, policy makers of member states need to “act collectively, and fast”.
13
 To counter
the pandemic, HCBC could be used concomitantly with HBC and population-wide COVID-
19 mitigation and suppression interventions such as wider social distancing. While HCBC 
represents a feasible and pertinent approach for preventing the HBC from becoming 
inadequate for surged COVID-19 pandemic in SSA, it is not a single magic bullet for 
mitigating the pandemic. 
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